Trial Outcomes & Findings for Study of Changes in the Feet With Pregnancy (NCT NCT01868074)

NCT ID: NCT01868074

Last Updated: 2016-08-02

Results Overview

Measurement of Arch Drop (Sitting arch height minus standing arch height) using Arch Height Index Measurement System

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

72 participants

Primary outcome timeframe

baseline, 8 weeks postpartum

Results posted on

2016-08-02

Participant Flow

Recruited from clinics affliated with the University of Iowa Hospitals and Clinics; from the clniical trials Website; and from local day care facilities, schools, and pregnancy excercise classes. Exclusion criteria included women participating in in vitro fertilization, previous lower limb or spinal surgery, \& chronic diseases.

Participant milestones

Participant milestones
Measure
Customized Insole Group
Each participant in the intervention group had her insole customized to fit her typical daily footwear and was instructed to wear the insoles as often as possible. Participants in the intervention group had their feet molded by a certified orthotist, using a 3M, soft cast. The casting was done in a non-weight bearing, hind-foot neutral position so the insoles would preserve the long transverse arch and maintain a biomechanically efficient state to control motion at the foot and ankle. These castings were used to custom form insoles with the following characteristics: Footlights athletic or dress model (per participant shoe preference), with 3/16" semi-rigid shells, no arch fill, extrinsic rearfoot and standard intrinsic forefoot posting. A research team member not involved with outcome measurements met with the participants to give them their insoles and confirm they fit.
Usual Care Group
Participants in the control group were instructed to wear their usual footwear over the course of their pregnancy.
Overall Study
STARTED
36
36
Overall Study
COMPLETED
29
32
Overall Study
NOT COMPLETED
7
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Customized Insole Group
Each participant in the intervention group had her insole customized to fit her typical daily footwear and was instructed to wear the insoles as often as possible. Participants in the intervention group had their feet molded by a certified orthotist, using a 3M, soft cast. The casting was done in a non-weight bearing, hind-foot neutral position so the insoles would preserve the long transverse arch and maintain a biomechanically efficient state to control motion at the foot and ankle. These castings were used to custom form insoles with the following characteristics: Footlights athletic or dress model (per participant shoe preference), with 3/16" semi-rigid shells, no arch fill, extrinsic rearfoot and standard intrinsic forefoot posting. A research team member not involved with outcome measurements met with the participants to give them their insoles and confirm they fit.
Usual Care Group
Participants in the control group were instructed to wear their usual footwear over the course of their pregnancy.
Overall Study
Lost to Follow-up
3
2
Overall Study
Withdrawal by Subject
4
2

Baseline Characteristics

Study of Changes in the Feet With Pregnancy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Customized Insole
n=36 Participants
These participants were casted for customized insoles.
Usual Care
n=36 Participants
Participants were instructed to wear their usual footwear over the course of their pregnancy.
Total
n=72 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
36 Participants
n=5 Participants
36 Participants
n=7 Participants
72 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
30.2 year
STANDARD_DEVIATION 4.6 • n=5 Participants
30.4 year
STANDARD_DEVIATION 4.4 • n=7 Participants
30.3 year
STANDARD_DEVIATION 4.5 • n=5 Participants
Sex: Female, Male
Female
36 Participants
n=5 Participants
36 Participants
n=7 Participants
72 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
36 participants
n=5 Participants
36 participants
n=7 Participants
72 participants
n=5 Participants
Foot Length Sitting
240.4 mm
STANDARD_DEVIATION 13.5 • n=5 Participants
240.1 mm
STANDARD_DEVIATION 10.2 • n=7 Participants
240.25 mm
STANDARD_DEVIATION 11.85 • n=5 Participants
Foot Length Standing
242.8 mm
STANDARD_DEVIATION 10.2 • n=5 Participants
243.0 mm
STANDARD_DEVIATION 13.7 • n=7 Participants
242.9 mm
STANDARD_DEVIATION 11.95 • n=5 Participants
AHI Sitting
0.35 ratio
STANDARD_DEVIATION 0.02 • n=5 Participants
0.35 ratio
STANDARD_DEVIATION 0.02 • n=7 Participants
0.35 ratio
STANDARD_DEVIATION 0.02 • n=5 Participants
AHI Standing
0.33 ratio
STANDARD_DEVIATION 0.02 • n=5 Participants
0.33 ratio
STANDARD_DEVIATION 0.02 • n=7 Participants
0.33 ratio
STANDARD_DEVIATION 0.02 • n=5 Participants
Arch Drop
3.0 mm
STANDARD_DEVIATION 1.4 • n=5 Participants
2.8 mm
STANDARD_DEVIATION 1.1 • n=7 Participants
2.9 mm
STANDARD_DEVIATION 1.3 • n=5 Participants
Arch Rigidity
0.94 ratio
STANDARD_DEVIATION 0.03 • n=5 Participants
0.94 ratio
STANDARD_DEVIATION .02 • n=7 Participants
0.94 ratio
STANDARD_DEVIATION 0.03 • n=5 Participants
Center of Pressure Excursion Index at self-selected speed
18.6 ratio
STANDARD_DEVIATION 6.2 • n=5 Participants
21.3 ratio
STANDARD_DEVIATION 6.3 • n=7 Participants
19.95 ratio
STANDARD_DEVIATION 6.25 • n=5 Participants
Center of Pressure Excursion Index (3mph)
18.1 ratio
STANDARD_DEVIATION 5.9 • n=5 Participants
20.8 ratio
STANDARD_DEVIATION 6.6 • n=7 Participants
19.9 ratio
STANDARD_DEVIATION 6.1 • n=5 Participants

PRIMARY outcome

Timeframe: baseline, 8 weeks postpartum

Measurement of Arch Drop (Sitting arch height minus standing arch height) using Arch Height Index Measurement System

Outcome measures

Outcome measures
Measure
Customized Insole Group
n=29 Participants
This intervention group were casted for customized insoles.
Usual Care Group
n=32 Participants
Participants in the control/usual group were instructed to wear their usual footwear over the course of their pregnancy.
Change in Arch Drop
-.02 mm
Standard Error .15
.07 mm
Standard Error .14

SECONDARY outcome

Timeframe: baseline, 8 weeks postpartum

The arch rigidity index, a measure of the ability of the foot to maintain the arch when weight-bearing, was determined by dividing the standing AHI by the seated AHI. A value of 1.0 would indicate a perfectly rigid arch, while smaller values would indicate a more flexible arch.

Outcome measures

Outcome measures
Measure
Customized Insole Group
n=29 Participants
This intervention group were casted for customized insoles.
Usual Care Group
n=32 Participants
Participants in the control/usual group were instructed to wear their usual footwear over the course of their pregnancy.
Change in Arch Rigidity
0 ratio
Standard Error 0
0 ratio
Standard Error 0

SECONDARY outcome

Timeframe: baseline, 8 weeks postpartum

The Center of Pressure Excursion Index (CPEI) is a measurement of the lateral displacement of the center of pressure curve from a reference line drawn from the initial to the final centers of pressure during stance phase of gait, and standardized to the width of the anterior third of the foot during pedobarography.

Outcome measures

Outcome measures
Measure
Customized Insole Group
n=29 Participants
This intervention group were casted for customized insoles.
Usual Care Group
n=32 Participants
Participants in the control/usual group were instructed to wear their usual footwear over the course of their pregnancy.
Change in CPEI (3mph)
.21 ratio
Standard Error .56
-.02 ratio
Standard Error .53

Adverse Events

Customized Insole

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Neil Segal, M.D., M.S.

University of Iowa

Phone: 3193560737

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place